What is the recommended management for acute and persistent pain after craniotomy?

Management of Acute and Persistent Post-Craniotomy Pain

For acute post-craniotomy pain, implement a multimodal opioid-sparing regimen combining scheduled acetaminophen, NSAIDs (if no bleeding concerns), scalp nerve block or incision infiltration with ropivacaine, intravenous dexmedetomidine infusion, and opioids only as rescue analgesia. 1

Acute Pain Management (First 48 Hours)

Core Pharmacological Strategy

The foundation of acute post-craniotomy pain control should include:

• Acetaminophen: Scheduled dosing provides moderate pain reduction at 12-24 hours with high-certainty evidence 2
• NSAIDs: Diclofenac or other NSAIDs show adequate pain control without adverse effects in craniotomy patients 3. However, avoid NSAIDs if patient is on therapeutic anticoagulation (enoxaparin, rivaroxaban, warfarin) as this multiplies bleeding risk by 2.5-fold 4
• Dexamethasone 8 mg IV: Administer at induction to reduce postoperative pain intensity 4

Regional Analgesia Techniques

Scalp nerve blocks or incision-site infiltration are essential components and should be performed in every craniotomy patient 1:

• Ropivacaine scalp block: High-certainty evidence shows significant pain reduction at 6 hours post-surgery 2
• Adding dexamethasone to bupivacaine for scalp blocks prolongs analgesia duration from median 420 minutes to 660 minutes, reduces opioid consumption at 12h, 24h, and 48h, and improves patient satisfaction 5
• Perform blocks either pre-incision or at wound closure

Intraoperative Adjuncts

Dexmedetomidine infusion: Provides adequate transitional analgesia and delays need for rescue opioids, though more research is needed for definitive dosing 1, 3

Opioid Use

Opioids should be rescue therapy only, not scheduled:

• Morphine or oxycodone orally when possible 4
• IV morphine for severe breakthrough pain
• PCA may be considered but is not first-line given the opioid-sparing approach 6

What NOT to Use

• Gabapentinoids preoperatively: Not recommended systematically for postoperative pain management 4
• Parecoxib: Not supported by evidence 3
• Ketamine: Only indicated for surgeries with high risk of chronic pain or in opioid-tolerant patients—not routine craniotomy 4

Persistent/Chronic Post-Craniotomy Pain (Beyond 3 Months)

Approximately 25% of patients develop persistent post-craniotomy headache 7. Recognize that chronic post-craniotomy pain often has neuropathic phenotypes requiring different management than acute pain.

Phenotype Recognition

Identify the specific pain pattern 8:

1. Occipital neuralgia-like pain (most common neuropathic phenotype)

   • Lancinating pain in occipital distribution
   • Trigger point tenderness over greater/lesser occipital nerves
   • Dermatomal distribution

2. Supraorbital/supratrochlear neuralgia (7.2% of neuropathic cases)

   • Frontal/frontotemporal pain after anterior craniotomies
   • Tenderness over supraorbital notch
   • Tinel sign along nerve course

3. Scar neuroma pain

   • Localized to incision site
   • Often coexists with regional neuralgias

Treatment Algorithm for Persistent Pain

First-line interventions:

• Occipital nerve blocks (with or without steroid) for occipital neuralgia phenotype 8
• Supraorbital/supratrochlear nerve blocks for frontal phenotype 8
• Neuropathic pain medications: Gabapentinoids (gabapentin/pregabalin) or SNRIs according to neuropathic pain guidelines 8

Second-line interventions:

• OnabotulinumtoxinA injections: Emerging evidence supports use for persistent post-craniotomy headache 7
• Pulsed radiofrequency ablation of occipital nerves for refractory occipital neuralgia 8

Adjunctive therapies:

• Cognitive behavioral therapy 9
• Transcutaneous electrical nerve stimulation (TENS) 9
• Acupuncture (limited evidence) 1

Critical Pitfalls

1. Bleeding risk with NSAIDs: Always verify coagulation status and anticoagulant use before prescribing NSAIDs. The combination with therapeutic anticoagulation is contraindicated 4

2. Delayed recognition of neuropathic pain: Median time from surgery to pain clinic referral is 12-18 months 8. Recognize neuropathic features early (lancinating quality, trigger points, dermatomal distribution) to initiate appropriate treatment sooner.

3. Over-reliance on opioids: Post-craniotomy pain responds well to multimodal non-opioid strategies. Opioids should be rescue only, not the foundation of treatment 1, 2.

4. Missing the regional block: Scalp blocks or infiltration are not optional—they are core components with high-certainty evidence for pain reduction 1, 2.

5. Inadequate preoperative planning: Patient education, pain history, and multimodal plan should be established preoperatively 6.